0.501
0.001 (0.2%)
0.001 (0.2%)
Upgrade to Real-Time
Afterhours (Closed)
| Volume | 1,955,237 |
|
|||||
| News | (2) | ||||||
| Day High | 0.5441 | Low High |
|||||
| Day Low | 0.485 | ||||||
Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| NovaBay Pharmaceuticals Inc New | NBY | AMEX | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
 |
|
|---|---|---|---|---|
| 0.001 | 0.2% | 0.501 | 19:59:55 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.50 | 0.485 | 0.5441 | 0.5214 | 0.50 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,388 | 1,955,237 | $ 0.5176673 | $ 1,012,162 | - | 0.45 - 1.79 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 20:00:00 | 720 | $ 0.5214 | USD |
Period:
Draw Mode:
NovaBay Pharmaceuticals Inc New Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 22.52M | 44.94M | 39.67M | $ 9.93M | $ -9.55M | -0.32 | -3.00 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | - | 4.40% |
NovaBay Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NBY Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.4505 | 0.55 | 0.4505 | 0.4960694 | 2,233,296 | 0.0505 | 11.21% |
| 1 Month | 0.517 | 0.63 | 0.45 | 0.5313592 | 1,089,674 | -0.016 | -3.09% |
| 3 Months | 0.65 | 0.77 | 0.45 | 0.5763351 | 933,563 | -0.149 | -22.92% |
| 6 Months | 0.70 | 0.8772 | 0.45 | 0.6364014 | 1,510,706 | -0.199 | -28.43% |
| 1 Year | 0.6065 | 1.79 | 0.45 | 0.948447 | 2,445,859 | -0.1055 | -17.39% |
| 3 Years | 1.28 | 4.78 | 0.20 | 1.14 | 2,189,945 | -0.779 | -60.86% |
| 5 Years | 4.00 | 5.00 | 0.20 | 1.15 | 1,324,739 | -3.50 | -87.48% |
NovaBay Pharmaceuticals Description
| NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops, manufactures, and markets anti-infective products for a multitude of uses. It is predominantly focused on commercializing prescription Avenova for the domestic eye care market in the United States. Avenova is the only eye care product formulated with proprietary, stable and pure form of hypochlorous acid (marketed as Neutrox). The company develops additional products containing Neutrox, including its NeutroPhase Skin and Wound Cleanser for wound care and CelleRx for the dermatology market. It has partnerships for NeutroPhase in the United States, as well as in other markets. |
